UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 20, 2004
RAMP CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
DELAWARE 0-24768 84-1123311
---------------------------- ------------ -------------------
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
33 Maiden Lane, New York, NY 10038
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(212) 440-1500
------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
-----------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events and Regulation FD Disclosure.
On July 20, 2004, Ramp Corporation (the "Company") issued a press
release announcing that it's wholly owned subsidiary HealthRamp has verified
better than expected preliminary results from its U.S. electronic prescribing
pilot project with Celltech Pharmaceuticals, Inc. A copy of that press release
is attached to this Form 8-K as Exhibit 99.1
S I G N A T U R E
-----------------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
RAMP CORPORATION
By: /s/ Andrew Brown
-----------------------------
Date: July 20, 2004 Name: Andrew Brown
Title: Chief Executive Officer and
President
EXHIBIT INDEX
Exhibit
Number Description
------ -----------
99.1 Press release of the Company dated July 20, 2004.